Cargando…

Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease

Plasma neurofilament light (NFL) has been proposed as a blood-based biomarker for neurodegeneration in Alzheimer’s disease (AD) and parkinsonian disorders. However, the relationship between plasma NFL and cognitive decline in dementia due to Parkinson’s disease (PD) remains to be elucidated. In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yung-Shuan, Lee, Wei-Ju, Wang, Shuu-Jiun, Fuh, Jong-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255914/ https://www.ncbi.nlm.nih.gov/pubmed/30478269 http://dx.doi.org/10.1038/s41598-018-35766-w

Ejemplares similares

Neurofilament light chain level in plasma extracellular vesicles and Parkinson’s disease
por: Chung, Chen-Chih, et al.
Publicado: (2020)

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
por: Batzu, Lucia, et al.
Publicado: (2022)

Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Two-year Follow-up Study
por: Lee, Wei-Ju, et al.
Publicado: (2018)

Plasma tau and neurofilament light chain as biomarkers of Alzheimer's disease and their relation to cognitive functions
por: Abed, Sadiruldeen Sami, et al.
Publicado: (2023)

Comparing Neurofilament Light Chain Levels in Serum and Plasma
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

Blood neurofilament light chain in Parkinson’s disease
por: Buhmann, Carsten, et al.
Publicado: (2023)

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
por: Giacomucci, Giulia, et al.
Publicado: (2022)

SORL1 gene, plasma biomarkers, and the risk of Alzheimer’s disease for the Han Chinese population in Taiwan
por: Chou, Cheng-Ta, et al.
Publicado: (2016)

The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer’s disease
por: Hsu, Jung-Lung, et al.
Publicado: (2017)

Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer’s disease
por: Hsu, Jung-Lung, et al.
Publicado: (2017)

Serum neurofilament light chain level as a predictor of cognitive stage transition
por: Lee, Eun-Hye, et al.
Publicado: (2022)

Association between Alzheimer’s disease genes and trajectories of cognitive function decline in Han Chinese in Taiwan
por: Hsieh, Tsung-Jen, et al.
Publicado: (2021)

Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults
por: He, Lingxiao, et al.
Publicado: (2021)

Plasma Neurofilament Light Chain Is Associated with Cognitive Impairment after Posterior Circulation Stroke
por: Jiang, Lianyan, et al.
Publicado: (2022)

Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer’s Disease and Mild Cognitive Impairment
por: Hsu, Jung-Lung, et al.
Publicado: (2015)

Plasma Neurofilament Light and Future Declines in Cognition and Function in Alzheimer’s Disease in the FIT-AD Trial
por: Li, Danni, et al.
Publicado: (2021)

Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
por: Kušnierová, Pavlína, et al.
Publicado: (2019)

Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
por: Sandelius, Åsa, et al.
Publicado: (2018)

Plasma neurofilament light chain concentration is increased in anorexia nervosa
por: Nilsson, Ida A. K., et al.
Publicado: (2019)

Plasma Neurofilament Light Chain Levels Are Elevated in Children and Young Adults With Wolfram Syndrome
por: Eisenstein, Sarah A., et al.
Publicado: (2022)

Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia
por: Tien, Yi-Ting, et al.
Publicado: (2019)

Plasma neurofilament light chain level predicts outcomes in stroke patients receiving endovascular thrombectomy
por: Chen, Chih-Hao, et al.
Publicado: (2021)

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
por: Chatterjee, Pratishtha, et al.
Publicado: (2019)

White matter hyperintensity, neurofilament light chain, and cognitive decline
por: Dhana, Anisa, et al.
Publicado: (2022)

Plasma levels of phosphorylated tau and neurofilament light chain as potential biomarkers for Alzheimer’s disease: A biochemical analysis in Pakistani population
por: Faraz Ahmed, Tehniat, et al.
Publicado: (2023)

Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China
por: Jiao, Bin, et al.
Publicado: (2021)

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
por: Mattsson, Niklas, et al.
Publicado: (2017)

Elevated Levels of Serum Neurofilament Light Chain Associated with Cognitive Impairment in Vascular Dementia
por: Ma, Weibin, et al.
Publicado: (2020)

Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology
por: Liu, Huei-Chun, et al.
Publicado: (2020)

Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
por: Rojas, Julio C., et al.
Publicado: (2016)

Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes
por: Ooi, Suyi, et al.
Publicado: (2022)

Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods
por: Chang, Kuo-Hsuan, et al.
Publicado: (2021)

Plasma levels of S100B and neurofilament light chain protein in stress-related mental disorders
por: Wallensten, Johanna, et al.
Publicado: (2022)

Neurofilament light chain plasma levels are associated with area of brain damage in experimental cerebral malaria
por: Wai, Chi Ho, et al.
Publicado: (2022)

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression
por: Mollenhauer, Brit, et al.
Publicado: (2020)

Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome
por: Wu, Chung-Hsin, et al.
Publicado: (2023)

Neurofilament light chain levels in MS: At the doorstep of clinical application
por: Dalmau, Josep
Publicado: (2019)

Increased levels of neurofilament light chain in suicide attempters’ serum
por: Ramezani, Mahtab, et al.
Publicado: (2022)

Neurofilament light chain: defining the analyte
por: Leckey, Claire A., et al.
Publicado: (2022)

Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease
por: Schultz, Stephanie A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4smqc33qobh5ga7pa8ijs6obum